Biotech · Private company
Tetraphase Pharmaceuticals, Inc
Track this companyFree. Adds Tetraphase Pharmaceuticals, Inc to your Dealase workspace and tells you when its record changes.
Clinical trials131 recruiting or active
Pipeline programs17From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline17
- EravacyclinePhase 3 · Complicated Intra-abdominal InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- EravacyclinePhase 3 · Complicated Urinary Tract InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- EravacyclinePhase 3 · cUTIClinicalTrials.gov · fetched Nov 12, 2026
- ErtapenemPhase 3 · Complicated Intra-abdominal InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- ErtapenemPhase 3 · Complicated Urinary Tract InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- LevofloxacinPhase 3 · cUTIClinicalTrials.gov · fetched Nov 12, 2026
- LevofloxacinPhase 3 · Complicated Urinary Tract InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- MeropenemPhase 3 · Complicated Intra-abdominal InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- ErtapenemPhase 2 · Complicated Intra-abdominal InfectionClinicalTrials.gov · fetched Nov 12, 2026
- IV Eravacycline 1.5mg/kgPhase 2 · Complicated Intra-abdominal Infections (cIAI)ClinicalTrials.gov · fetched Nov 12, 2026
- IV Eravacycline 2mg/kgPhase 2 · Complicated Intra-abdominal Infections (cIAI)ClinicalTrials.gov · fetched Nov 12, 2026
- TP-434Phase 2 · Complicated Intra-abdominal InfectionClinicalTrials.gov · fetched Nov 12, 2026
- eravacyclinePhase 1 · Impaired Hepatic FunctionClinicalTrials.gov · fetched Nov 12, 2026
- Eravacycline (TP-434)Phase 1 · Bacterial InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- TP-271Phase 1 · Bacterial InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- TP-271Phase 1 · PneumoniaClinicalTrials.gov · fetched Nov 12, 2026
- TP-434 (Eravacycline) reconstituted and administered via an IV infusionPhase 1 · Normal Drug ToleranceClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials13
- A Study to Evaluate the Safety and Tolerability of Eravacycline in Pediatric Patients Aged 8 to 17 With Complicated Intra-abdominal Infections (cIAI)PHASE2 · RECRUITING · started May 22, 2025ClinicalTrials.gov NCT06794541 · fetched Nov 12, 2026
- A Safety and PK Study of IV EravacyclinePHASE1 · COMPLETED · started Dec 20, 2018ClinicalTrials.gov NCT03696550 · fetched Nov 12, 2026
- A Phase 1 TP-271 Oral PK Multiple Ascending Dose StudyPHASE1 · COMPLETED · started Mar 20, 2018ClinicalTrials.gov NCT03450187 · fetched Nov 12, 2026
- A Phase 1 Safety and PK Study of IV TP-271PHASE1 · COMPLETED · started Aug 16, 2017ClinicalTrials.gov NCT03234738 · fetched Nov 12, 2026
- A Phase 1 TP-271 Oral PK Single Ascending Dose StudyPHASE1 · COMPLETED · started Mar 2, 2017ClinicalTrials.gov NCT03024034 · fetched Nov 12, 2026
- Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Participants With Complicated Urinary Tract InfectionsPHASE3 · COMPLETED · started Jan 1, 2017ClinicalTrials.gov NCT03032510 · fetched Nov 12, 2026
- Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal InfectionsPHASE3 · COMPLETED · started Oct 13, 2016ClinicalTrials.gov NCT02784704 · fetched Nov 12, 2026
- A Phase 1 Study to Assess the Safety, Tolerability and PK of IV TP-271PHASE1 · COMPLETED · started Dec 18, 2015ClinicalTrials.gov NCT02724085 · fetched Nov 12, 2026
- Efficacy and Safety Study of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract InfectionsPHASE3 · COMPLETED · started Oct 6, 2014ClinicalTrials.gov NCT01978938 · fetched Nov 12, 2026
- A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With Impaired Hepatic Function and Healthy SubjectsPHASE1 · COMPLETED · started Oct 1, 2013ClinicalTrials.gov NCT02135302 · fetched Nov 12, 2026
- Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal InfectionsPHASE3 · COMPLETED · started Aug 1, 2013ClinicalTrials.gov NCT01844856 · fetched Nov 12, 2026
- Safety and Pharmacokinetic (PK) Study to Assess Bronchopulmonary Disposition of IV Eravacycline (TP-434) in Healthy Men and WomenPHASE1 · COMPLETED · started Nov 1, 2012ClinicalTrials.gov NCT01989949 · fetched Nov 12, 2026
- Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal InfectionsPHASE2 · COMPLETED · started Jan 1, 2011ClinicalTrials.gov NCT01265784 · fetched Nov 12, 2026